Viral Kansara is the VP of Development at Clearside Biomedical, where he leverages over 17 years of experience transforming molecules into approved medicines. He specializes in ophthalmic drug discovery and has led numerous programs through all stages of development. Colleagues describe him as brilliant, patient, collaborative, and proficient, highlighting his strength in team leadership and clear communication.
There is no publicly available information regarding Virals personal life or hobbies.
He played a key role in the FDA approval of XIPERE, the first commercial therapy delivered via the suprachoroidal space, a significant innovation in treating eye diseases.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.